IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,280,000 | +140.2% | 109,141 | +0.1% | 0.15% | +112.5% |
| Q2 2020 | $3,863,000 | +163.0% | 109,000 | 0.0% | 0.07% | +100.0% |
| Q1 2020 | $1,469,000 | -52.1% | 109,000 | -24.8% | 0.04% | -35.7% |
| Q4 2019 | $3,068,000 | +59.5% | 145,000 | 0.0% | 0.06% | +47.4% |
| Q3 2019 | $1,923,000 | -4.4% | 145,000 | 0.0% | 0.04% | -44.1% |
| Q2 2019 | $2,011,000 | -27.8% | 145,000 | 0.0% | 0.07% | -38.2% |
| Q1 2019 | $2,785,000 | +34.6% | 145,000 | 0.0% | 0.11% | +25.0% |
| Q4 2018 | $2,069,000 | -31.5% | 145,000 | 0.0% | 0.09% | -17.8% |
| Q3 2018 | $3,020,000 | -12.0% | 145,000 | 0.0% | 0.11% | -18.9% |
| Q2 2018 | $3,432,000 | +62.0% | 145,000 | 0.0% | 0.13% | +63.0% |
| Q1 2018 | $2,118,000 | -9.6% | 145,000 | 0.0% | 0.08% | -8.0% |
| Q4 2017 | $2,343,000 | +15.6% | 145,000 | 0.0% | 0.09% | +12.8% |
| Q3 2017 | $2,027,000 | +58.4% | 145,000 | 0.0% | 0.08% | +56.0% |
| Q2 2017 | $1,280,000 | +36.5% | 145,000 | 0.0% | 0.05% | +35.1% |
| Q1 2017 | $938,000 | +76.3% | 145,000 | 0.0% | 0.04% | +68.2% |
| Q4 2016 | $532,000 | +13.0% | 145,000 | 0.0% | 0.02% | +15.8% |
| Q3 2016 | $471,000 | +40.2% | 145,000 | 0.0% | 0.02% | +35.7% |
| Q2 2016 | $336,000 | -20.9% | 145,000 | -14.7% | 0.01% | -17.6% |
| Q1 2016 | $425,000 | -29.0% | 170,000 | -12.8% | 0.02% | -29.2% |
| Q4 2015 | $599,000 | +78.8% | 195,000 | 0.0% | 0.02% | +84.6% |
| Q3 2015 | $335,000 | -57.7% | 195,000 | 0.0% | 0.01% | -50.0% |
| Q2 2015 | $792,000 | +6.0% | 195,000 | 0.0% | 0.03% | +8.3% |
| Q1 2015 | $747,000 | -20.2% | 195,000 | 0.0% | 0.02% | -20.0% |
| Q4 2014 | $936,000 | – | 195,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|